Article
Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor relapse
23 Apr 2025
Abstract excerpt
Colorectal cancer molecular signatures derived from omics data can be employed to stratify CRC patients and aid decisions about therapies or evaluate prognostic outcome. However, molecular biomarkers for identification of patients at increased risk of disease relapse are currently lacking. Here, we present a comprehensive multi-omics analysis of a Danish colorectal cancer tumor cohort composed of 412 biopsies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
